Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Median Effective Dose of Esketamine Pretreatment to Prevent Sufentanil-induced Cough
NCT05809804Unknown
- Sponsor
- Yangzhou University
- Start
- Apr 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
01
Overview
Trial of esketamine (2 arms), sponsored by Yangzhou University. Primary endpoint: The presence of cough at 1 minute. Status: unknown.
02
Drugs
esketamine
Beyond the preview
Go deeper on NCT05809804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05809804.